FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Massimo Franchini

Research Profile

Disorders

Chemicals & Drugs

Physiology

Hemostasis

Procedures

Blood Coagulation Tests

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Massimo Franchini; Giuseppe Lippi; Dino Veneri; Giovanni Targher; Marco Zaffanello; Gian Cesare Guidi
Inherited platelet disorders.
Massimo Franchini; Marco Zaffanello; Dino Veneri; Giuseppe Lippi
Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitors.
Massimo Franchini; Giuseppe Lippi
Acquired von Willebrand syndrome: an update.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Massimo Franchini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2008: Massimo Franchini; Giuseppe Lippi; Dino Veneri; Giovanni Targher; Marco Zaffanello; Gian Cesare Guidi
Inherited platelet disorders.
Clinica chimica acta; international journal of clinical chemistry 2008;387(1-2):1-8.
2007: Massimo Franchini; Marco Zaffanello; Dino Veneri; Giuseppe Lippi
Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitors.
Pediatric blood & cancer 2007;49(1):6-10.
2007: Massimo Franchini; Giuseppe Lippi
Acquired von Willebrand syndrome: an update.
American journal of hematology 2007;82(5):368-75.
2006: Massimo Franchini; D Girelli; O Olivieri; Giancarlo Castaman; Giuseppe Lippi; G Poli; G L Salvagno; Giuseppe Tagariello; Annachiara Giuffrida; Marzia De Gironcoli; Massimo Morfini; E Berntorp; Giorgio Gandini
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(4):448-51.
2006: Massimo Franchini
Hemostatic changes in thyroid diseases: haemostasis and thrombosis.
Hematology (Amsterdam, Netherlands) 2006;11(3):203-8.
2006: Massimo Franchini
Onset of severe refractory thrombocytopenia following surgery in a patient with type 2B von Willebrand disease--a case report.
Hematology (Amsterdam, Netherlands) 2006;11(2):127-9.
2006: Massimo Franchini; Giuseppe Lippi; Franco Manzato
Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation.
Thrombosis journal 2006;4():4.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.